UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics

Diagnostics (Basel), 2023-02, Vol.13 (4), p.721

Kostara, Christina E

2023

Volltextzugriff (PDF)

Insulin resistance and cardiovascular disease

Journal of International Medical Research, 2023-03, Vol.51 (3), p.3000605231164548-3000605231164548

2023

Volltextzugriff (PDF)

Effect of Clinical and Laboratory Parameters on HDL Particle Composition

International journal of molecular sciences, 2023-01, Vol.24 (3), p.1995

2023

Volltextzugriff (PDF)

Environmental Factors Modifying HDL Functionality

Current medicinal chemistry, 2022-01, Vol.29 (10), p.1687

2022

Volltextzugriff (PDF)

Lipidomics in non-alcoholic fatty liver disease

World journal of hepatology, 2020-08, Vol.12 (8), p.436-450

2020

Volltextzugriff (PDF)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8835

2020

Volltextzugriff (PDF)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

Diagnostics (Basel), 2023-03, Vol.13 (5), p.929

2023

Volltextzugriff (PDF)

Altered RBC membrane lipidome: A possible etiopathogenic link for the microvascular impairment in Type 2 diabetes

Journal of diabetes and its complications, 2021-10, Vol.35 (10), p.107998-107998, Article 107998

2021

Volltextzugriff (PDF)

NMR-Based Lipid Profiling of High Density Lipoprotein Particles in Healthy Subjects with Low, Normal, and Elevated HDL-Cholesterol

Journal of proteome research, 2017-04, Vol.16 (4), p.1605-1616

2017

Volltextzugriff (PDF)

Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes

Metabolites, 2022-07, Vol.12 (8), p.683

2022

Volltextzugriff (PDF)

Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities

Cells (Basel, Switzerland), 2022-08, Vol.11 (17), p.2719

2022

Volltextzugriff (PDF)

A Study of the Metabolic Pathways Affected by Gestational Diabetes Mellitus: Comparison with Type 2 Diabetes

Diagnostics (Basel), 2022-11, Vol.12 (11), p.2881

2022

Volltextzugriff (PDF)

NMR-Based Lipidomic Analysis of Blood Lipoproteins Differentiates the Progression of Coronary Heart Disease

Journal of proteome research, 2014-05, Vol.13 (5), p.2585-2598

2014

Volltextzugriff (PDF)

Lipidome of plasma lipoproteins and liver is zinc- modulated in High fat diet treated mice

Journal of trace elements in medicine and biology, 2018-12, Vol.50, p.268-275

2018

Volltextzugriff (PDF)

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study

Clinical therapeutics, 2010-03, Vol.32 (3), p.492-505

2010

Volltextzugriff (PDF)

Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles

Lipids, 2007-05, Vol.42 (5), p.403-409

2007

Volltextzugriff (PDF)

Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine

Neuroscience letters, 2009-07, Vol.25 (7), p.729-735

2009

Volltextzugriff (PDF)

Comparison of predictive equations for resting metabolic rate in obese psychiatric patients taking olanzapine

Nutrition (Burbank, Los Angeles County, Calif.), 2009-02, Vol.25 (2), p.188-193

2009

Volltextzugriff (PDF)

Evaluation of Established Coronary Heart Disease on the Basis of HDL and Non-HDL NMR Lipid Profiling

Journal of proteome research, 2010-02, Vol.9 (2), p.897-911

2010

Volltextzugriff (PDF)

THU-134 Metabolomic signature by 1H-NMR spectroscopy discriminates autoimmune hepatitis from other liver diseases

Journal of hepatology, 2024-06, Vol.80, p.S325-S326

2024

Volltextzugriff (PDF)

THU-126 Metabolomic signature in autoimmune hepatitis discriminates disease activity and predicts response to treatment

Journal of hepatology, 2024-06, Vol.80, p.S322-S322

2024

Volltextzugriff (PDF)

Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes

Journal of diabetes and its complications, 2022-10, Vol.36 (10), p.108286-108286, Article 108286

2022

Volltextzugriff (PDF)

Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study

NMR in biomedicine, 2009-12, Vol.22 (10), p.1072-1083

2009

Volltextzugriff (PDF)

SAT060 - Unrevealing the HDL lipidome in NAFLD: a possible explanation for the increased CVD risk of these patients

Journal of hepatology, 2020-08, Vol.73, p.S681-S681

2020

Volltextzugriff (PDF)

Unrevealing the HDL lipidome in NAFLD: a possible explanation for the increased CVD risk of these patients

Journal of hepatology, 2020-08, Vol.73, p.S681

2020

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics

Insulin resistance and cardiovascular disease

Effect of Clinical and Laboratory Parameters on HDL Particle Composition

Environmental Factors Modifying HDL Functionality

Lipidomics in non-alcoholic fatty liver disease

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

Altered RBC membrane lipidome: A possible etiopathogenic link for the microvascular impairment in Type 2 diabetes

NMR-Based Lipid Profiling of High Density Lipoprotein Particles in Healthy Subjects with Low, Normal, and Elevated HDL-Cholesterol

Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes

Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities

A Study of the Metabolic Pathways Affected by Gestational Diabetes Mellitus: Comparison with Type 2 Diabetes

NMR-Based Lipidomic Analysis of Blood Lipoproteins Differentiates the Progression of Coronary Heart Disease

Lipidome of plasma lipoproteins and liver is zinc- modulated in High fat diet treated mice

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study

Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles

Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine

Comparison of predictive equations for resting metabolic rate in obese psychiatric patients taking olanzapine

Evaluation of Established Coronary Heart Disease on the Basis of HDL and Non-HDL NMR Lipid Profiling

THU-134 Metabolomic signature by 1H-NMR spectroscopy discriminates autoimmune hepatitis from other liver diseases

THU-126 Metabolomic signature in autoimmune hepatitis discriminates disease activity and predicts response to treatment

Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes

Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study

SAT060 - Unrevealing the HDL lipidome in NAFLD: a possible explanation for the increased CVD risk of these patients

Unrevealing the HDL lipidome in NAFLD: a possible explanation for the increased CVD risk of these patients

Suchergebnisse filtern